Clinical Trials Browser

OTHER × Interventional × Metastatic Castration-Resistant Prostate Cancer × Clear all

NCT04419402 2024-02-07

ENZA-p

Phase 2 Unknown

Metastatic Castration-Resistant Prostate Cancer

NCT02125357 2020-08-07

Sequencing Abiraterone and Enzalutamide in mCRPC

Phase 2 Completed

Metastatic Castration-Resistant Prostate Cancer

NCT02091531 2019-11-21

Dual mTOR Inhibitor MLN0128 in Advanced Castration-Resistant Prostate Cancer (CRPC) Patients

Phase 2 Completed

9 enrolled 10 charts

Metastatic Castration-Resistant Prostate Cancer